BOLT vs ILMN · rev $7.7M vs rev $4.34B
Bolt Biotherapeutics (BOLT) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
BOLT currently screens at market cap $11.3M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the BOLT and ILMN stock pages for the full models.
Not investment advice.